About
Peptide Therapies
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyJapan
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
38
By Phase
PHASE2: 1PHASE1: 1
By Status
TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT03417882Lead Sponsor
GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC
PHASE2Terminated
20 participants
Started: Jan 3, 2019 · Completed: Dec 5, 2022
NCT02696356Lead Sponsor
Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma
PHASE1Completed
18 participants
Started: Apr 30, 2016 · Completed: Mar 31, 2018
Locations (1)
Headquarters
Tokyo, Japan
Map
Loading map...